A new method replicated the findings of a previous clinical trial of Tecfidera in people with relapsing-remitting MS, a study ...

Living with multiple sclerosis is challenging enough without hunting for specialists or waiting months for an appointment.

Real-world use of an MS blood test shows how it helps monitor disease activity and guide treatment decisions in U.S. patients ...

“This study found that having bladder problems was significantly associated with lower well-being in [people with] MS, particularly when considering OAB. Bowel problems, self-management of bladder ...

A new study published in the Journal of Neurology1 detailed the development of 2 machine learning–based tools that were able ...

Findings from this study showed that initial preferences for a good, long-term safety profile and relapse prevention among people with MS who started on a new DMT remained highly relevant throughout ...

Andrew N. Wilner, MD: This is Dr Andrew Wilner, reporting for Medscape. Today I have the pleasure of interviewing Dr John Carter, Associate Professor at the Mayo Clinic, and a specialist in multiple ...

A compassionate neurofeedback game that can identify fatigue aims to help patients with MS, according to a poster presented ...

Subcutaneous ocrelizumab (SC OCR) maintains a safety profile similar to intravenous administration in multiple sclerosis patients. A 920 mg SC OCR dose was identified as optimal, with mild to moderate ...

NATIONAL HARBOR, Maryland — Though evidence is mounting that low vitamin D levels may increase risk for the development and perhaps progression of multiple sclerosis, clinicians still do not have ...

Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...